Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content | JCO Clinical Cancer Informatics
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Chemotherapy regimens for breast cancer. | Download Table
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial - The Lancet Oncology
Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel... | Download Table
SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer | Breast Cancer ...
Chemotherapy Administration Sequencing: An Update on the Current Literature
Pregnancy-Associated Breast Cancer
Dose-dense chemotherapy for breast cancer: what does the future hold? | Future Oncology
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
PDF) Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel (Dose Dense AC Followed by T) Regimen for Breast Cancer
Recommended antiemetic regimens for HEC and AC-containing regimens... | Download Table
Breast Cancer Update .com - Web Guide 1 2003
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial - The Lancet Regional Health – Western Pacific
4102-Breast adjuvant/neoadjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense | eviQ
AC Chemotherapy Regimen (Doxorubicin + Cyclophosphamide) - PDF Free Download
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Chemotherapy Protocol
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802) - Annals of Oncology
National Surgical Adjuvant Breast and Bowel Project (NSABP)
1607-Breast adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense followed by PACLitaxel dose de | eviQ
PDF) Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel (Dose Dense AC Followed by T) Regimen for Breast Cancer
Chemotherapy protocol a for HR ALL patients | Download Table
Chemotherapy-Induced Nausea and Vomiting: From Guideline to Clinical Practice - Pharmacy Connection
Chemotherapy for Uterus Cancer
Update on systemic treatment for newly diagnosed inflammatory breast cancer - ScienceDirect
Dexamethasone-Sparing Strategies Using Netupitant and Palonosetron Fixed-Dose Combination for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting: A Case Series
